December 22, 2014 3:35 PM ET

Capital Markets

Company Overview of CapRegen Ltd.

Company Overview

CapRegen Ltd. is a principal investment arm of Tarsus Group plc. It prefers to invest in the anti-ageing and regenerative medicine sector. The firm invests in companies based in the North America region. It typically invests in non-FDA regulated technologies for one to three years from commercialisation and in FDA regulated technologies for five to seven years. CapRegen Ltd. was founded on June 26, 2007 and is based in London, United Kingdom.

4th Floor Metro Building

1 Butterwick Hammersmith

London,  W6 8DL

United Kingdom

Founded in 2007

Phone:

44 20 8846 2708

Key Executives for CapRegen Ltd.

Executive Director
Age: 59
Executive Director
Age: 59
Company Secretary
Compensation as of Fiscal Year 2014.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CapRegen Ltd., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.